Showing results (271-280 of 367) with videos related to

Sort By:
Pageof 37
Journal of Pediatric Surgery|June 1, 1993
Maturational dysautonomia and facial anomalies associated with esophageal atresia: support for neural crest involvementF Cozzi, N A Myers, S Piacenti, et al.
European Journal of Clinical Investigation|February 1, 1988
Red blood cell sodium and potassium fluxes in psoriatic patientsA Semplicini, M G Mozzato, E Rigon, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|April 16, 2008
[Occupational contact dermatitis in metal workers and gender effect]F Larese Filon, G Marzioti, A Belloni Fortina, et al.
Carcinogenesis|June 1, 1993
Genetic heterogeneity of the excision repair defect associated with trichothiodystrophyM Stefanini, P Lagomarsini, S Giliani, et al.
The British Journal of Dermatology|February 1, 1988
Relationship between body weight and blood pressure and some metabolic parameters in psoriatic patientsA Peserico, G Zanetti, S Padovan, et al.
Archivos Del Instituto De Cardiologia De Mexico|May 1, 1992
[An electro- and vectorcardiographic study of ventricular activation in scleroderma]G Cardin, R Garro, M C Caporale, et al.
International Journal of Antimicrobial Agents|September 8, 2005
Evaluation of telithromycin against Streptococcus pneumoniae with ribosomal mutations utilizing in vitro time-kill methodologyPrachi K Dandekar, Pamela R Tessier, David J Farrell, et al.
The Journal of Infectious Diseases|September 1, 1995
Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulareC O Onyeji, C H Nightingale, P R Tessier, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
In vitro reduction of endotoxin concentrations with the 5S fragment of immunoglobulin GD Xuan, D P Nicolau, P R Tessier, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2011
In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organismsCatharine C Bulik, Pamela R Tessier, Rebecca A Keel, et al.
Pageof 37